1 Min Read
* Says it received China mainland patent(No. ZL201310492386.8), for Anti-IL6 human monoclonal antibody new drug FB704A
Source text in Chinese: goo.gl/wjJ1S7
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.